CEACAM8（抗原遺伝子）の世界市場レポート2020

• 英文タイトル：Global CEACAM8(Antigen gene) Sales Market Report 2020

• レポートコード：20QY06-00156 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、CEACAM8（抗原遺伝子）のグローバル市場について種類別（90％以上、95％以上、99％以上、その他）、用途別（バイオ製薬会社、病院、バイオサイエンス研究機関、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・CEACAM8（抗原遺伝子）市場の概要 ・世界の主要地域別CEACAM8（抗原遺伝子）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のCEACAM8（抗原遺伝子）市場規模2015-2026：種類別（90％以上、95％以上、99％以上、その他） ・世界のCEACAM8（抗原遺伝子）市場規模2015-2026：用途別（バイオ製薬会社、病院、バイオサイエンス研究機関、その他） ・CEACAM8（抗原遺伝子）の北米市場規模2015-2020 ・CEACAM8（抗原遺伝子）のヨーロッパ市場規模2015-2020 ・CEACAM8（抗原遺伝子）の中国市場規模2015-2020 ・CEACAM8（抗原遺伝子）の日本市場規模2015-2020 ・CEACAM8（抗原遺伝子）の東南アジア市場規模2015-2020 ・CEACAM8（抗原遺伝子）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Aviva Systems Biology Corporation(USA)、Abbexa Ltd(UK)、ProSci(US)、Boster Biological Technology(USA)、Biobyt(UK)、Bio-Rad(US)、Bioss Antibodies(US)、R&D Systems(US)、BioLegend(US)、Stemcell(Canada)、Thermo Fisher Scientific(US)、USBiological(US)、EnzoLifeSciences(Switzerland)、Genetex(US)、Lifespan Biosciences(US)、Novus Biologicals(US)） ・CEACAM8（抗原遺伝子）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・CEACAM8（抗原遺伝子）の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global CEACAM8(Antigen gene) Market
The global CEACAM8(Antigen gene) market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global CEACAM8(Antigen gene) Scope and Market Size
The global CEACAM8(Antigen gene) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CEACAM8(Antigen gene) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the CEACAM8(Antigen gene) market is segmented into
Above 90%
Above 95%
Above 99%
Others

Segment by Application, the CEACAM8(Antigen gene) market is segmented into
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
The CEACAM8(Antigen gene) market is analysed and market size information is provided by regions (countries). Segment by Application, the CEACAM8(Antigen gene) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and CEACAM8(Antigen gene) Market Share Analysis
CEACAM8(Antigen gene) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in CEACAM8(Antigen gene) business, the date to enter into the CEACAM8(Antigen gene) market, CEACAM8(Antigen gene) product introduction, recent developments, etc.
The major vendors covered:
Aviva Systems Biology Corporation(USA)
Abbexa Ltd(UK)
ProSci(US)
Boster Biological Technology(USA)
Biobyt(UK)
Bio-Rad(US)
Bioss Antibodies(US)
R&D Systems(US)
BioLegend(US)
Stemcell(Canada)
Thermo Fisher Scientific(US)
USBiological(US)
EnzoLifeSciences(Switzerland)
Genetex(US)
Lifespan Biosciences(US)
Novus Biologicals(US)

レポート目次

---

Table of Contents

1 CEACAM8(Antigen gene) Market Overview
1.1 CEACAM8(Antigen gene) Product Scope
1.2 CEACAM8(Antigen gene) Segment by Type
1.2.1 Global CEACAM8(Antigen gene) Sales by Type (2020-2026)
1.2.2 Above 90%
1.2.3 Above 95%
1.2.4 Above 99%
1.2.5 Others
1.3 CEACAM8(Antigen gene) Segment by Application
1.3.1 Global CEACAM8(Antigen gene) Sales Comparison by Application (2020-2026)
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 CEACAM8(Antigen gene) Market Estimates and Forecasts (2015-2026)
1.4.1 Global CEACAM8(Antigen gene) Sales Growth Rate (2015-2026)
1.4.2 Global CEACAM8(Antigen gene) Revenue and Growth Rate (2015-2026)
1.4.3 Global CEACAM8(Antigen gene) Price Trends (2015-2026)

2 CEACAM8(Antigen gene) Estimate and Forecast by Region
2.1 Global CEACAM8(Antigen gene) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global CEACAM8(Antigen gene) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global CEACAM8(Antigen gene) Sales Market Share by Region (2015-2020)
2.2.2 Global CEACAM8(Antigen gene) Revenue Market Share by Region (2015-2020)
2.3 Global CEACAM8(Antigen gene) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global CEACAM8(Antigen gene) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global CEACAM8(Antigen gene) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States CEACAM8(Antigen gene) Estimates and Projections (2015-2026)
2.4.2 Europe CEACAM8(Antigen gene) Estimates and Projections (2015-2026)
2.4.3 China CEACAM8(Antigen gene) Estimates and Projections (2015-2026)
2.4.4 Japan CEACAM8(Antigen gene) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia CEACAM8(Antigen gene) Estimates and Projections (2015-2026)
2.4.6 India CEACAM8(Antigen gene) Estimates and Projections (2015-2026)
3 Global CEACAM8(Antigen gene) Competition Landscape by Players
3.1 Global Top CEACAM8(Antigen gene) Players by Sales (2015-2020)
3.2 Global Top CEACAM8(Antigen gene) Players by Revenue (2015-2020)
3.3 Global CEACAM8(Antigen gene) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CEACAM8(Antigen gene) as of 2019)
3.4 Global CEACAM8(Antigen gene) Average Price by Company (2015-2020)
3.5 Manufacturers CEACAM8(Antigen gene) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key CEACAM8(Antigen gene) Players (Opinion Leaders)
4 Global CEACAM8(Antigen gene) Market Size by Type
4.1 Global CEACAM8(Antigen gene) Historic Market Review by Type (2015-2020)
4.1.1 Global CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
4.1.2 Global CEACAM8(Antigen gene) Revenue Market Share by Type (2015-2020)
4.1.3 Global CEACAM8(Antigen gene) Price by Type (2014-2020)
4.2 Global CEACAM8(Antigen gene) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global CEACAM8(Antigen gene) Sales Forecast by Type (2021-2026)
4.2.2 Global CEACAM8(Antigen gene) Revenue Forecast by Type (2021-2026)
4.2.3 Global CEACAM8(Antigen gene) Price Forecast by Type (2021-2026)
5 Global CEACAM8(Antigen gene) Market Size by Application
5.1 Global CEACAM8(Antigen gene) Historic Market Review by Application (2015-2020)
5.1.1 Global CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)
5.1.2 Global CEACAM8(Antigen gene) Revenue Market Share by Application (2015-2020)
5.1.3 Global CEACAM8(Antigen gene) Price by Application (2015-2020)
5.2 Global CEACAM8(Antigen gene) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global CEACAM8(Antigen gene) Sales Forecast by Application (2021-2026)
5.2.2 Global CEACAM8(Antigen gene) Revenue Forecast by Application (2021-2026)
5.2.3 Global CEACAM8(Antigen gene) Price Forecast by Application (2021-2026)

3 North America CEACAM8(Antigen gene) Market Facts & Figures
3.2 North America CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
3.3 North America CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
3.4 North America CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)

4 Europe CEACAM8(Antigen gene) Market Facts & Figures
4.2 Europe CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
4.3 Europe CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
4.4 Europe CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)

5 China CEACAM8(Antigen gene) Market Facts & Figures
5.2 China CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
5.3 China CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
5.4 China CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)

6 Japan CEACAM8(Antigen gene) Market Facts & Figures
6.2 Japan CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
6.3 Japan CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
6.4 Japan CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)

7 Southeast Asia CEACAM8(Antigen gene) Market Facts & Figures
7.2 Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)

8 India CEACAM8(Antigen gene) Market Facts & Figures
8.2 India CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
8.3 India CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
8.4 India CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in CEACAM8(Antigen gene) Business
12.1 Aviva Systems Biology Corporation(USA)
12.1.1 Aviva Systems Biology Corporation(USA) CEACAM8(Antigen gene) Corporation Information
12.1.2 Aviva Systems Biology Corporation(USA) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.1.3 Aviva Systems Biology Corporation(USA) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Aviva Systems Biology Corporation(USA) CEACAM8(Antigen gene) Products Offered
12.1.5 Aviva Systems Biology Corporation(USA) Recent Development
12.2 Abbexa Ltd(UK)
12.2.1 Abbexa Ltd(UK) CEACAM8(Antigen gene) Corporation Information
12.2.2 Abbexa Ltd(UK) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.2.3 Abbexa Ltd(UK) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbexa Ltd(UK) CEACAM8(Antigen gene) Products Offered
12.2.5 Abbexa Ltd(UK) Recent Development
12.3 ProSci(US)
12.3.1 ProSci(US) CEACAM8(Antigen gene) Corporation Information
12.3.2 ProSci(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.3.3 ProSci(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ProSci(US) CEACAM8(Antigen gene) Products Offered
12.3.5 ProSci(US) Recent Development
12.4 Boster Biological Technology(USA)
12.4.1 Boster Biological Technology(USA) CEACAM8(Antigen gene) Corporation Information
12.4.2 Boster Biological Technology(USA) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.4.3 Boster Biological Technology(USA) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boster Biological Technology(USA) CEACAM8(Antigen gene) Products Offered
12.4.5 Boster Biological Technology(USA) Recent Development
12.5 Biobyt(UK)
12.5.1 Biobyt(UK) CEACAM8(Antigen gene) Corporation Information
12.5.2 Biobyt(UK) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.5.3 Biobyt(UK) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biobyt(UK) CEACAM8(Antigen gene) Products Offered
12.5.5 Biobyt(UK) Recent Development
12.6 Bio-Rad(US)
12.6.1 Bio-Rad(US) CEACAM8(Antigen gene) Corporation Information
12.6.2 Bio-Rad(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.6.3 Bio-Rad(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bio-Rad(US) CEACAM8(Antigen gene) Products Offered
12.6.5 Bio-Rad(US) Recent Development
12.7 Bioss Antibodies(US)
12.7.1 Bioss Antibodies(US) CEACAM8(Antigen gene) Corporation Information
12.7.2 Bioss Antibodies(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.7.3 Bioss Antibodies(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bioss Antibodies(US) CEACAM8(Antigen gene) Products Offered
12.7.5 Bioss Antibodies(US) Recent Development
12.8 R&D Systems(US)
12.8.1 R&D Systems(US) CEACAM8(Antigen gene) Corporation Information
12.8.2 R&D Systems(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.8.3 R&D Systems(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 R&D Systems(US) CEACAM8(Antigen gene) Products Offered
12.8.5 R&D Systems(US) Recent Development
12.9 BioLegend(US)
12.9.1 BioLegend(US) CEACAM8(Antigen gene) Corporation Information
12.9.2 BioLegend(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.9.3 BioLegend(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 BioLegend(US) CEACAM8(Antigen gene) Products Offered
12.9.5 BioLegend(US) Recent Development
12.10 Stemcell(Canada)
12.10.1 Stemcell(Canada) CEACAM8(Antigen gene) Corporation Information
12.10.2 Stemcell(Canada) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.10.3 Stemcell(Canada) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Stemcell(Canada) CEACAM8(Antigen gene) Products Offered
12.10.5 Stemcell(Canada) Recent Development
12.11 Thermo Fisher Scientific(US)
12.11.1 Thermo Fisher Scientific(US) CEACAM8(Antigen gene) Corporation Information
12.11.2 Thermo Fisher Scientific(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.11.3 Thermo Fisher Scientific(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Thermo Fisher Scientific(US) CEACAM8(Antigen gene) Products Offered
12.11.5 Thermo Fisher Scientific(US) Recent Development
12.12 USBiological(US)
12.12.1 USBiological(US) CEACAM8(Antigen gene) Corporation Information
12.12.2 USBiological(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.12.3 USBiological(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 USBiological(US) CEACAM8(Antigen gene) Products Offered
12.12.5 USBiological(US) Recent Development
12.13 EnzoLifeSciences(Switzerland)
12.13.1 EnzoLifeSciences(Switzerland) CEACAM8(Antigen gene) Corporation Information
12.13.2 EnzoLifeSciences(Switzerland) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.13.3 EnzoLifeSciences(Switzerland) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 EnzoLifeSciences(Switzerland) CEACAM8(Antigen gene) Products Offered
12.13.5 EnzoLifeSciences(Switzerland) Recent Development
12.14 Genetex(US)
12.14.1 Genetex(US) CEACAM8(Antigen gene) Corporation Information
12.14.2 Genetex(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.14.3 Genetex(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Genetex(US) CEACAM8(Antigen gene) Products Offered
12.14.5 Genetex(US) Recent Development
12.15 Lifespan Biosciences(US)
12.15.1 Lifespan Biosciences(US) CEACAM8(Antigen gene) Corporation Information
12.15.2 Lifespan Biosciences(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.15.3 Lifespan Biosciences(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Lifespan Biosciences(US) CEACAM8(Antigen gene) Products Offered
12.15.5 Lifespan Biosciences(US) Recent Development
12.16 Novus Biologicals(US)
12.16.1 Novus Biologicals(US) CEACAM8(Antigen gene) Corporation Information
12.16.2 Novus Biologicals(US) CEACAM8(Antigen gene) Business Overview and Total Revenue
12.16.3 Novus Biologicals(US) CEACAM8(Antigen gene) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Novus Biologicals(US) CEACAM8(Antigen gene) Products Offered
12.16.5 Novus Biologicals(US) Recent Development

13 CEACAM8(Antigen gene) Manufacturing Cost Analysis
13.1 CEACAM8(Antigen gene) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of CEACAM8(Antigen gene)
13.4 CEACAM8(Antigen gene) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 CEACAM8(Antigen gene) Distributors List
14.3 CEACAM8(Antigen gene) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global CEACAM8(Antigen gene) Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global CEACAM8(Antigen gene) Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market CEACAM8(Antigen gene) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global CEACAM8(Antigen gene) Sales (K MT) by Region (2015-2020)
Table 5. Global CEACAM8(Antigen gene) Sales Market Share by Region (2015-2020)
Table 6. Global CEACAM8(Antigen gene) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global CEACAM8(Antigen gene) Revenue Share by Region (2015-2020)
Table 8. Global CEACAM8(Antigen gene) Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global CEACAM8(Antigen gene) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global CEACAM8(Antigen gene) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global CEACAM8(Antigen gene) Revenue Share Forecast by Region (2021-2026)
Table 12. Global CEACAM8(Antigen gene) (K MT) of Key Companies (2015-2020)
Table 13. Global CEACAM8(Antigen gene) Sales Share by Company (2015-2020)
Table 14. Global CEACAM8(Antigen gene) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global CEACAM8(Antigen gene) Revenue Share by Company (2015-2020)
Table 16. Global CEACAM8(Antigen gene) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CEACAM8(Antigen gene) as of 2019)
Table 17. Global CEACAM8(Antigen gene) Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers CEACAM8(Antigen gene) Manufacturing Sites and Area Served
Table 19. Manufacturers CEACAM8(Antigen gene) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key CEACAM8(Antigen gene) Players
Table 22. Global CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 23. Global CEACAM8(Antigen gene) Sales Share by Type (2015-2020)
Table 24. Global CEACAM8(Antigen gene) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global CEACAM8(Antigen gene) Price (K MT) by Type (2015-2020)
Table 26. Global CEACAM8(Antigen gene) Sales Share by Type (2021-2026)
Table 27. Global CEACAM8(Antigen gene) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global CEACAM8(Antigen gene) Revenue Share by Type (2021-2026)
Table 29. Global CEACAM8(Antigen gene) Price (K MT) by Type (2021-2026)
Table 30. Global CEACAM8(Antigen gene) Sales (K MT) by Application (2015-2020)
Table 31. Global CEACAM8(Antigen gene) Sales Share by Application (2015-2020)
Table 32. Global CEACAM8(Antigen gene) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global CEACAM8(Antigen gene) Price (K MT) by Application (2015-2020)
Table 34. Global CEACAM8(Antigen gene) Sales (K MT) by Application (2021-2026)
Table 35. Global CEACAM8(Antigen gene) Sales Share by Application (2021-2026)
Table 36. Global CEACAM8(Antigen gene) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global CEACAM8(Antigen gene) Revenue Share by Application (2021-2026)
Table 38. Global CEACAM8(Antigen gene) Price (K MT) by Application (2021-2026)
Table 39. United States CEACAM8(Antigen gene) Sales (K MT) by Company (2015-2020)
Table 40. United States CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
Table 41. United States CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 42. United States CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 43. United States CEACAM8(Antigen gene) Sales (K MT) by Application (2015-2020)
Table 44. United States CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)
Table 45. Europe CEACAM8(Antigen gene) Sales (K MT) by Company (2015-2020)
Table 46. Europe CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
Table 47. Europe CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 48. Europe CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 49. Europe CEACAM8(Antigen gene) Sales (K MT) by Application (2015-2020)
Table 50. Europe CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 51. China CEACAM8(Antigen gene) Sales (K MT) by Company (2015-2020)
Table 52. China CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
Table 53. China CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 54. China CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 55. China CEACAM8(Antigen gene) Sales (K MT) by Application (2015-2020)
Table 56. China CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)
Table 57. Japan CEACAM8(Antigen gene) Sales (K MT) by Company (2015-2020)
Table 58. Japan CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
Table 59. Japan CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 60. Japan CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 61. Japan CEACAM8(Antigen gene) Sales (K MT) by Application (2015-2020)
Table 62. Japan CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia CEACAM8(Antigen gene) Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)
Table 69. India CEACAM8(Antigen gene) Sales (K MT) by Company (2015-2020)
Table 70. India CEACAM8(Antigen gene) Sales Market Share by Company (2015-2020)
Table 71. India CEACAM8(Antigen gene) Sales (K MT) by Type (2015-2020)
Table 72. India CEACAM8(Antigen gene) Sales Market Share by Type (2015-2020)
Table 73. India CEACAM8(Antigen gene) Sales (K MT) by Application (2015-2020)
Table 74. India CEACAM8(Antigen gene) Sales Market Share by Application (2015-2020)
Table 75. Aviva Systems Biology Corporation(USA) Corporation Information
Table 76. Aviva Systems Biology Corporation(USA) Description and Business Overview
Table 77. Aviva Systems Biology Corporation(USA) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Aviva Systems Biology Corporation(USA) CEACAM8(Antigen gene) Product
Table 79. Aviva Systems Biology Corporation(USA) Recent Development
Table 80. Abbexa Ltd(UK) Corporation Information
Table 81. Abbexa Ltd(UK) Description and Business Overview
Table 82. Abbexa Ltd(UK) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Abbexa Ltd(UK) CEACAM8(Antigen gene) Product
Table 84. Abbexa Ltd(UK) Recent Development
Table 85. ProSci(US) Corporation Information
Table 86. ProSci(US) Description and Business Overview
Table 87. ProSci(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. ProSci(US) CEACAM8(Antigen gene) Product
Table 89. ProSci(US) Recent Development
Table 90. Boster Biological Technology(USA) Corporation Information
Table 91. Boster Biological Technology(USA) Description and Business Overview
Table 92. Boster Biological Technology(USA) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Boster Biological Technology(USA) CEACAM8(Antigen gene) Product
Table 94. Boster Biological Technology(USA) Recent Development
Table 95. Biobyt(UK) Corporation Information
Table 96. Biobyt(UK) Description and Business Overview
Table 97. Biobyt(UK) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Biobyt(UK) CEACAM8(Antigen gene) Product
Table 99. Biobyt(UK) Recent Development
Table 100. Bio-Rad(US) Corporation Information
Table 101. Bio-Rad(US) Description and Business Overview
Table 102. Bio-Rad(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Bio-Rad(US) CEACAM8(Antigen gene) Product
Table 104. Bio-Rad(US) Recent Development
Table 105. Bioss Antibodies(US) Corporation Information
Table 106. Bioss Antibodies(US) Description and Business Overview
Table 107. Bioss Antibodies(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Bioss Antibodies(US) CEACAM8(Antigen gene) Product
Table 109. Bioss Antibodies(US) Recent Development
Table 110. R&D Systems(US) Corporation Information
Table 111. R&D Systems(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. R&D Systems(US) Description and Business Overview
Table 113. R&D Systems(US) CEACAM8(Antigen gene) Product
Table 114. R&D Systems(US) Recent Development
Table 115. BioLegend(US) Corporation Information
Table 116. BioLegend(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. BioLegend(US) Description and Business Overview
Table 118. BioLegend(US) CEACAM8(Antigen gene) Product
Table 119. BioLegend(US) Recent Development
Table 120. Stemcell(Canada) Corporation Information
Table 121. Stemcell(Canada) Description and Business Overview
Table 122. Stemcell(Canada) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Stemcell(Canada) CEACAM8(Antigen gene) Product
Table 124. Stemcell(Canada) Recent Development
Table 125. Thermo Fisher Scientific(US) Corporation Information
Table 126. Thermo Fisher Scientific(US) Description and Business Overview
Table 127. Thermo Fisher Scientific(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Thermo Fisher Scientific(US) CEACAM8(Antigen gene) Product
Table 129. Thermo Fisher Scientific(US) Recent Development
Table 130. USBiological(US) Corporation Information
Table 131. USBiological(US) Description and Business Overview
Table 132. USBiological(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. USBiological(US) CEACAM8(Antigen gene) Product
Table 134. USBiological(US) Recent Development
Table 135. EnzoLifeSciences(Switzerland) Corporation Information
Table 136. EnzoLifeSciences(Switzerland) Description and Business Overview
Table 137. EnzoLifeSciences(Switzerland) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. EnzoLifeSciences(Switzerland) CEACAM8(Antigen gene) Product
Table 139. EnzoLifeSciences(Switzerland) Recent Development
Table 140. Genetex(US) Corporation Information
Table 141. Genetex(US) Description and Business Overview
Table 142. Genetex(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Genetex(US) CEACAM8(Antigen gene) Product
Table 144. Genetex(US) Recent Development
Table 145. Lifespan Biosciences(US) Corporation Information
Table 146. Lifespan Biosciences(US) Description and Business Overview
Table 147. Lifespan Biosciences(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Lifespan Biosciences(US) CEACAM8(Antigen gene) Product
Table 149. Lifespan Biosciences(US) Recent Development
Table 150. Novus Biologicals(US) Corporation Information
Table 151. Novus Biologicals(US) Description and Business Overview
Table 152. Novus Biologicals(US) CEACAM8(Antigen gene) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Novus Biologicals(US) CEACAM8(Antigen gene) Product
Table 154. Novus Biologicals(US) Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. CEACAM8(Antigen gene) Distributors List
Table 158. CEACAM8(Antigen gene) Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. CEACAM8(Antigen gene) Product Picture
Figure 2. Global CEACAM8(Antigen gene) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global CEACAM8(Antigen gene) Market Share by Application in 2020 & 2026
Figure 6. Biopharmaceutical Companies Examples
Figure 7. Hospitals Examples
Figure 8. Bioscience Research Institutions Examples
Figure 9. Others Examples
Figure 10. Global CEACAM8(Antigen gene) Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global CEACAM8(Antigen gene) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global CEACAM8(Antigen gene) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global CEACAM8(Antigen gene) Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global CEACAM8(Antigen gene) Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States CEACAM8(Antigen gene) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States CEACAM8(Antigen gene) Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe CEACAM8(Antigen gene) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe CEACAM8(Antigen gene) Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China CEACAM8(Antigen gene) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China CEACAM8(Antigen gene) Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan CEACAM8(Antigen gene) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan CEACAM8(Antigen gene) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia CEACAM8(Antigen gene) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia CEACAM8(Antigen gene) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India CEACAM8(Antigen gene) Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India CEACAM8(Antigen gene) Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest CEACAM8(Antigen gene) Players Market Share by Revenue in CEACAM8(Antigen gene) 2015 & 2019
Figure 28. CEACAM8(Antigen gene) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global CEACAM8(Antigen gene) Revenue Share by Type (2015-2020)
Figure 30. Global CEACAM8(Antigen gene) Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global CEACAM8(Antigen gene) Revenue Share by Application (2015-2020)
Figure 32. Global CEACAM8(Antigen gene) Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 34. United States CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 35. Europe CEACAM8(Antigen gene) Sales Market Share by Company in 2019
Figure 36. Europe CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 37. Europe CEACAM8(Antigen gene) Sales Market Share by Application in 2019
Figure 38. China CEACAM8(Antigen gene) Sales Market Share by Company in 2019
Figure 39. China CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 40. China CEACAM8(Antigen gene) Sales Market Share by Application in 2019
Figure 41. Japan CEACAM8(Antigen gene) Sales Market Share by Company in 2019
Figure 42. Japan CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 43. Japan CEACAM8(Antigen gene) Sales Market Share by Application in 2019
Figure 44. Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Company in 2019
Figure 45. Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 46. Southeast Asia CEACAM8(Antigen gene) Sales Market Share by Application in 2019
Figure 47. India CEACAM8(Antigen gene) Sales Market Share by Company in 2019
Figure 48. India CEACAM8(Antigen gene) Sales Market Share by Type in 2019
Figure 49. India CEACAM8(Antigen gene) Sales Market Share by Application in 2019
Figure 50. Aviva Systems Biology Corporation(USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Abbexa Ltd(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. ProSci(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Boster Biological Technology(USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Biobyt(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bio-Rad(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bioss Antibodies(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. R&D Systems(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. BioLegend(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Stemcell(Canada) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Thermo Fisher Scientific(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. USBiological(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. EnzoLifeSciences(Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Genetex(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Lifespan Biosciences(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Novus Biologicals(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of CEACAM8(Antigen gene)
Figure 68. Manufacturing Process Analysis of CEACAM8(Antigen gene)
Figure 69. CEACAM8(Antigen gene) Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---